Ailin

What Ailin does

Ailin (legal entity Home Diagnostics S.L.) is a Spain-based digital health diagnostics company founded in 2021 by Isabel Caruana and headquartered in Madrid. The company operates a consumer-facing platform (ailin.es) that delivers at-home self-sampling kits for blood, urine, and breath collection, with samples routed to accredited clinical laboratories — including Clínica Universidad de Navarra and Reference Lab — for analysis. Results are returned in 24–48 hours through a digital portal (myhealth.ailin.es) with AI-generated medical interpretation and personalized recommendations. Test kits are CE-marked medical devices regulated by AEMPS, and the platform holds ISO 27001 and ISO 27701 certifications; a clinical validation study with Clínica Universidad de Navarra confirmed diagnostic equivalence between at-home self-sampling and traditional venipuncture.

The product portfolio spans more than 30 at-home tests across five categories: preventive health (cardiovascular, diabetes, prostate cancer markers), functional health (vitamins, weight control, testosterone), digestive health (SIBO, lactose, fructose, celiac), sexual health (7- and 11-pathogen STI panels), and hormonal health (cortisol, TSH, fertility). An additional B2B module, Ailin for Professionals, provides a dedicated portal for healthcare providers and pharmaceutical-led screening programs, with deployments reported across seven European countries.

The business model combines direct-to-consumer e-commerce (one-time purchases priced €39.99–€149.99) with subscription plans (monthly through annual cadences, offering 10–20% discounts and multi-kit minimum commitments) on the consumer side, and B2B2C professional services for clinics, hospitals, occupational health programs, and pharmaceutical screening partners. The company closed its first institutional funding round of €1.5M in February 2024 from CDTI (public) and Decelera Ventures (private), with stated use of proceeds for AI algorithm development and team expansion. As of the most recent disclosure, Ailin has served more than 5,000 customers and analyzed more than 25,000 biomarkers, with 1–10 employees and an 80% reported user satisfaction rate.

Name

Ailin

Legal name

Home Diagnostics S.L.

Website

https://ailin.es

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Ailin (Home Diagnostics S.L.) is a Madrid-based digital health company that sells CE-marked at-home self-sampling kits — analyzed by accredited labs including Clínica Universidad de Navarra — with AI-interpreted results delivered to consumers and a B2B portal for healthcare providers and pharmaceutical screening programs across Europe.

Ownership category

akta.pro rank

Product category

Home Health Diagnostics

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• At-home lab testing
• Preventive health diagnostics
• Clinical diagnostic kits
• Biomarker testing services
• Digital health platform

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Direct product sales (e-commerce): One-time purchases of individual test kits through the company's e-commerce website (ailin.es). Customers pay per test at published price points ranging from ~€39.99 to €149.99 depending on complexity. This is the primary revenue stream for the consumer segment.
2. Subscription plans: Recurring subscription model with monthly, quarterly (trimestral), semi-annual (semestral), and annual billing cadences. Subscribers receive discounts of up to 10–20% on listed prices. Subscriptions auto-renew and require minimum kit delivery before cancellation is permitted (e.g., 3 kits minimum for monthly plan, 2 for others). Generates predictable recurring revenue from returning customers.
3. Professional / B2B services: B2B offering targeted at healthcare professionals and providers, enabling them to deploy at-scale prevention programs using Ailin's platform, kits, and AI-supported interpretation. Revenue may include professional services or volume-based kit procurement. The company also references collaboration with large pharmaceutical companies on screening programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Ailin sells CE-marked at-home self-collection test kits (blood, breath, urine) covering preventive, functional, digestive, sexual, and hormonal health, with samples processed by accredited laboratories such as Clínica Universidad de Navarra and Reference Lab. Results are delivered through the myhealth.ailin.es platform in 24–48 hours with AI-powered medical interpretation and personalized recommendations, supported by subscription plans (monthly, quarterly, semi-annual, annual). A separate Ailin for Professionals offering enables healthcare providers and pharmaceutical companies to deploy at-scale screening and prevention programs using the same kit, lab, and AI infrastructure.

Product overview

Ailin is a home-based health diagnostics platform that offers a unified portfolio of direct-to-consumer at-home laboratory test kits and a professional-facing module. The core product is a digital health platform connecting home sample collection (blood, breath, urine) with accredited laboratory analysis and AI-powered medical interpretation, delivering results in 24–48 hours. The consumer offering spans five health categories: Salud Preventiva (preventive health), Salud Funcional (functional health), Salud Digestiva (digestive health), Salud Sexual (sexual health), and Salud Hormonal (hormonal health). Individual products include named test kits such as the SIBO Test, Testosterone Test, Celiac Disease Test, and multi-panel tests (7 ITS and 11 ITS panels), all delivered through the main platform at ailin.es. An additional module, Ailin for Professionals, provides a B2B offering for healthcare professionals to deploy prevention programs at scale, powered by the same AI and laboratory infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

• Ailin Home Health Testing Platform Digital platform that lets users self-collect biological samples (blood, breath, urine) at home, send them to accredited partner laboratories, and receive AI-interpreted clinical results with personalized medical recommendations within 24–48 hours via the myhealth.ailin.es portal.
• Vitamin D Test At-home blood test measuring vitamin D levels with medical interpretation included; available as a one-time purchase (€39.99) or via subscription with up to 20% savings.
• Essential Vitamins Test At-home test measuring vitamin D, B12, and folic acid levels with medical interpretation included; available with a subscription option offering up to 10% savings (€69.99 per test).
• Testosterone Test At-home blood test measuring testosterone levels to detect alterations associated with fatigue, low sexual desire, or mood changes; available with a subscription option (€54.99 per test, up to 10% subscription savings).
• Advanced Stress Test At-home test measuring cortisol, TSH, and C-reactive protein (CRP) to assess the impact of chronic stress; available as an Advanced Pack with subscription option (€79.99 per test, up to 10% subscription savings).
• Weight Control Test At-home test identifying hormonal causes that hinder weight loss, providing personalized insights for weight management; available with a subscription option (€89.99 per test, up to 10% subscription savings).
• SIBO Test At-home breath test kit detecting small intestinal bacterial overgrowth (SIBO) by measuring hydrogen and methane curves; one-time purchase priced at €68.00 (discounted from €107.00), with results delivered in 7–10 days.
• Cardiovascular Risk – Lp(a) Test At-home blood test measuring lipoprotein(a), a genetic marker of cardiac risk, to assess cardiovascular disease risk; one-time purchase at €69.00 per test.
• 7 ITS (7-Pathogen STI Panel) Test At-home sexual health test detecting HIV, syphilis, hepatitis B and C, chlamydia, gonorrhea, and trichomoniasis; available with a subscription option (€119.99 per test, up to 10% subscription savings).
• 11 ITS (11-Pathogen STI Panel) Test At-home sexual health test detecting 11 infections across blood and urine; Ailin's most comprehensive STI panel, available with a subscription option (€149.99 per test, up to 10% subscription savings).
• Celiac Disease Test At-home blood test screening for celiac disease by measuring IgA anti-transglutaminase antibodies; endorsed by the Spanish Ministry of Health.
• Ailin for Professionals B2B platform for healthcare professionals offering accessible at-home tests, accredited laboratory analysis, simplified clinical management at scale, patient accompaniment, and AI trained by and for physicians; supports population screening, workplace health assessments, and international screening programs across seven European countries.

Quantifiable outcome

• 80% customer satisfaction rate
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Clínica Universidad de Navarra (CUN)coreTechnology or IntegrationClínica Universidad de Navarra conducted a clinical validation study for Ailin's at-home sampling kits, confirming that results from self-collection are equivalent to those obtained via venipuncture in clinical settings. CUN is referenced as one of the accredited laboratories processing Ailin test samples.
• Reference LabcoreTechnology or IntegrationReference Lab is listed as one of the accredited clinical laboratories partnered with Ailin for sample analysis. Ailin works exclusively with certified laboratories (CAP and ISO 15189 accredited) for all test processing.
• Large pharmaceutical companies (international programs)minorStrategic or Co-development PartnerAilin is collaborating with unnamed major pharmaceutical companies to deploy international screening and diagnosis programs in seven European countries. This represents an emerging B2B2C channel for population-scale health screening.
• Google for StartupsminorGTM or Marketing PartnerAilin is featured and supported by Google for Startups program, providing credibility, potential cloud credits, and technology ecosystem integration.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Mediktor: Spain-based AI symptom assessment and triage platform used by health systems and insurers. Comparable Spanish digital-health origin with AI-for-clinicians positioning, though Mediktor focuses on pre-diagnostic triage rather than lab diagnostics.

Direct peers

• LetsGetChecked: Ireland/US-based home diagnostics company offering self-collected test kits with physician-reviewed results and pharmacy/B2B partnerships. Closest international peer to Ailin in DTC self-sampling + AI-supported interpretation across multiple health categories.
• Cerascreen: German home diagnostics company selling self-sampling kits (vitamins, hormones, food intolerances, STIs) with app-based results. Direct European peer with overlapping test catalog, subscription model, and B2C e-commerce motion.
• Thriva: UK-based home blood-testing subscription service offering biomarker tracking with personalized health insights. Comparable subscription model, at-home phlebotomy, and AI-driven reporting.
• GetTested: Swedish home diagnostics company providing self-sampling kits across hormones, STIs, and wellness categories with European-wide shipping. Direct competitor in the European home-test kit space with similar CE-marked product strategy.
• Everlywell: US-based home diagnostics leader offering DTC self-collection kits with lab processing and digital results. Closest US peer in business model and product breadth, useful as a benchmark for category scale.
• Numan: UK digital health platform combining at-home blood testing with clinician consultations and personalized treatment plans. Comparable subscription + biomarker tracking motion with integrated telehealth layer.
• myLAB Box: US home STI and wellness testing company selling self-collection kits with lab analysis. Overlaps with Ailin's STI panel category (7 ITS, 11 ITS) and direct-to-consumer e-commerce model.

Broad incumbents

• Quest Diagnostics: Large US clinical laboratory network expanding into direct-to-consumer home test kits and digital health partnerships. Represents the incumbent lab-services model that Ailin's partner labs (e.g., Reference Lab) compete within.
• Eurofins Genomics: Global clinical diagnostics and lab services group with strong European footprint. Relevant as a potential lab partner competitor and as a benchmark for European diagnostic-services scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ailin5211
• LinkedInlinkedin.com/company/ailin-health
• Instagraminstagram.com/ailin.health
• Facebookfacebook.com/Ailin.Health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ailin